Clinical Trial Update: A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the Body [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study in Chinese adults with overweight or obesity to evaluate how different doses of Survodutide are absorbed, with the trial status re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Survodutide (BI456906)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Overweight, Obesity | Phase 1 | Status: COMPLETED